기본 정보
- 표준 SMILES
O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl- InChIKey
AGHANLSBXUWXTB-UHFFFAOYSA-N- 분자식
- C13H8Cl2O4S
- 평균 분자량
- 331.2 g/mol
- 단동위원소 질량
- 329.9520351
개요
Tienilic acid is an aromatic ketone that is 2,3-dichlorophenoxyacetic acid in which the hydrogen at position 4 on the benzene ring is replaced by a thiophenecarbonyl group. A loop diuretic used to treat hypertension, it was withdrawn from the market in 1982 due to links with hepatitis. It has a role as an antihypertensive agent, a hepatotoxic agent and a loop diuretic. It is a dichlorobenzene, a monocarboxylic acid, a member of thiophenes, an aromatic ether and an aromatic ketone.
이름 및 식별자
- 우선 이름
- Tienilic Acid
- IUPAC
- 2-[2,3-dichloro-4-(thiophene-2-carbonyl)phenoxy]acetic acid
- 현지명
- 티크리나펜
- 영어명
- TICRYNAFEN
- 분자식
- C13H8Cl2O4S
- 분자량
- 331.17
이름 및 동의어
이름 더 보기
데이터베이스 식별자
- CAS
40180-04-9- PubChem CID
- 38409
- DTXSID
DTXSID4023670- ChEMBL
CHEMBL267744- ChEBI
CHEBI:9590- UNII
- HC95205SY4
- EC Number
- 254-826-3
- Nikkaji
- J16.869F
물성
구조 계산 물성
- XLogP
- 4.1
- 극성 표면적
- 91.8 Ų
- 수소 결합 공여자 수
- 1
- 수소 결합 수용자 수
- 5
- 회전 가능 결합 수
- 5
- 무거운 원자 수
- 20
- 형식 전하
- 0
- 복잡도
- 379
실험 및 물리화학적 성질
물리화학적 성질
- 녹는점
- 148 · 148-149oC
- 끓는 점
- 534.6 · 534.6±50.0 °C(Predicted)
- 밀도
- 1.532 · 1.532
- 저장 조건
- -20 °C · -20°C
- 용해도
- 5 mg/mL · DMSO: 가용성5mg/mL(투명 용액)
- 산도 계수 (pKa)
- 2.79 · 2.79±0.10(Predicted)
- 물리적 상태
- 가루
- 색상
- 흰색에서 베이지색
- InChI
- InChI=1S/C13H8Cl2O4S/c14-11-7(13(18)9-2-1-5-20-9)3-4-8(12(11)15)19-6-10(16)17/h1-5H,6H2,(H,16,17)
- InChIKey
- AGHANLSBXUWXTB-UHFFFAOYSA-N
- SMILES
- C(O)(=O)COC1=CC=C(C(C2SC=CC=2)=O)C(Cl)=C1Cl
화학적 성질
Pale Beige Solid
안전 및 규제
GHS 분류
GHS Classification
Warning
H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
유해성 정보
독성 정보
Drug Induced Liver Injury
Drug Induced Liver Injury Rank (DILIrank 2.0)
Ticrynafen
vMost-DILI-concern
8
Withdrawn
DOI:10.1016/j.drudis.2016.02.015
안전 데이터
- wgk
- 3
- rtecs
- AG9300000
- 독성
- LD50 in mice (mg/kg): 225 i.v., 1275 orally (US 3758506)
- risk_code
- 22
- hazard_code
- Xn
- 스토리지 클래스
- 11 - Combustible Solids
화학 및 산업
약리 정보
ATC Code
C - Cardiovascular system
QC - Cardiovascular system
MeSH Pharmacological Classification
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Agents that promote the excretion of urine through their effects on kidney function.
Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma.
응용 분야
용도A heterocycloc derivative of phenoxyacetic Acid. Uses as a diuretic, uricosuric, anhtihypertensive
공급사50 곳
추가 설명
정의ChEBI: An aromatic ketone that is 2,3-dichlorophenoxyacetic acid in which the hydrogen at position 4 on the benzene ring is replaced by a thiophenecarbonyl group. A loop diuretic used to treat hypertension, it was withdrawn from the market in 1982 due to links wi h hepatitis.
관련 반응
연결된 노트
불러오는 중…